Schedule 13D ownership disclosure

Aurinia Pharmaceuticals Inc

Common Shares, no par value · CUSIP: 05156V102

Event date: 2025-08-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ILJIN SNT Co., Ltd.Reported CIK 0001772596

    Shares: 5,411,533.00 · Class: 4.1%

  • ILJIN Steel Co., Ltd.

    Shares: 1,123,608.00 · Class: 0.9%

  • ILJIN GLS Co., Ltd.

    Shares: 5,411,533.00 · Class: 4.1%

  • Sae Kyoung Huh

    Shares: 465,766.00 · Class: 0.4%

  • Seoung Eun Huh

    Shares: 392,188.00 · Class: 0.3%

  • Chin Kyu Huh

    Shares: 6,535,141.00 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-077809
Form type
SCHEDULE 13D/A
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Aug 13, 2025
Reporting period
Aug 11, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub